monitor
antibodi
level
pair
camel
dam
calv
monthli
interv
cours
year
postparturit
anim
born
rais
close
commerci
camel
dairi
farm
unit
arab
emir
strict
anim
health
biosecur
program
total
number
camel
farm
anim
kept
open
paddock
group
accord
age
calv
product
stage
despit
high
standard
hygien
husbandri
biosecur
transmiss
pathogen
within
farm
complet
elimin
therefor
entir
farm
epidemiolog
unit
pair
investig
studi
kept
differ
fenc
compart
within
howev
anim
kept
togeth
pair
paddock
throughout
lactat
camel
calv
born
june
nasal
swab
specimen
taken
mother
calv
serum
sampl
obtain
jugular
vein
punctur
blood
cell
remov
immedi
collect
sampl
store
test
serum
sampl
nasal
swab
taken
day
parturit
week
month
postparturit
monthli
interv
june
merscov
rna
detect
amplif
gene
target
describ
previous
viru
isol
perform
vero
cell
igg
neutral
antibodi
determin
elisa
microneutr
test
describ
previous
gener
matern
igg
antibodi
camel
acquir
via
transplacent
rout
intak
colostrum
first
hour
postparturit
hour
antibodi
level
dam
milk
decreas
rapidli
igg
level
calv
serum
ceas
rise
pattern
reflect
merscov
studi
day
parturit
sampl
collect
pair
studi
high
level
antibodi
observ
dam
wherea
antibodi
detect
calv
figur
panel
day
postparturit
howev
camel
calv
high
antibodi
level
level
declin
first
month
postparturit
wherea
igg
dam
remain
constantli
high
level
neutral
activ
igg
confirm
microneutr
test
serum
sampl
calv
collect
month
month
year
birth
figur
panel
b
month
serum
calv
complet
lost
neutral
activ
remain
calv
low
neutral
titer
rang
figur
panel
b
examin
possibl
correl
antibodi
merscov
infect
examin
shed
merscov
nasal
swab
specimen
first
month
postparturit
merscov
rna
detect
sporad
day
tabl
infecti
viru
isol
calv
dam
month
postparturit
calv
show
lowest
antibodi
titer
merscov
rna
detect
calv
tabl
indic
activ
merscov
infect
calv
seroconvert
follow
week
figur
panel
calf
meanwhil
euthan
congenit
forelimb
deform
calv
show
high
reciproc
neutral
titer
month
postparturit
longitudin
studi
natur
merscov
infect
camel
confirm
assumpt
preliminari
crosssect
studi
camel
merscov
infect
appear
predominantli
affect
young
immunolog
naiv
anim
serum
antibodi
might
suffici
mediat
protect
immun
respiratori
tract
dam
calv
sporad
infect
even
matern
antibodi
peak
day
postparturit
find
consist
earlier
report
merscov
reinfect
seroposit
camel
nevertheless
find
viru
isol
calv
dam
line
earlier
observ
reduc
viral
load
seroposit
camel
reinfect
indic
neutral
antibodi
might
provid
steril
immun
could
still
reduc
viral
replic
level
predomin
infect
young
anim
better
explain
absenc
immun
factor
social
group
densiti
number
newborn
camel
studi
neglig
compar
overal
size
herd
farm
moreov
young
camel
kept
contigu
group
small
compart
contact
mother
young
anim
calv
like
infect
fomit
adult
anim
shed
low
quantiti
viru
find
import
implic
prevent
human
infect
camel
herd
manag
camel
vaccin
camel
breed
even
involv
small
number
newborn
anim
classifi
risk
human
acquisit
merscov
greatest
risk
assum
time
fourth
month
life
first
wave
natur
infect
occur
first
year
life
camel
rais
region
measur
prevent
infect
person
protect
equip
hand
hygien
environment
sanit
appli
farm
studi
suffici
protect
given
human
merscov
ill
occur
among
staff
worker
regular
contact
camel
detect
igg
antibodi
person
underli
diseas
elderli
show
sever
outcom
merscov
infect
group
gener
avoid
farm
camel
calv
rais
result
also
suggest
studi
deal
applic
efficaci
merscov
vaccin
modifi
first
studi
involv
immunolog
naiv
anim
show
sharp
declin
viru
secret
vaccin
howev
futur
vaccin
trial
also
investig
effect
preexist
matern
antibodi
vaccin
efficaci
